Delve into the world of Myeloproliferative Neoplasms (MPNs) with Prof. Heinz Gisslinger, a distinguished figure in Hematology. Prof. Gisslinger's expertise covers a spectrum of blood disorders, making him a pioneer in MPN research. In this exclusive and enlightening interview, he generously shares profound insights into the evolving landscape of MPN treatments, including the promising drug, Besremi.
From the Global MPN Scientific Foundation, we collaborate with Patients, Physicians, and Pharma (3P's), fostering insights and advancements in the realm of Myeloproliferative Neoplasms (MPNs). Prof. Heinz Gisslinger's interview enriches our understanding, emphasizing the collective effort needed to drive progress and enhance the lives of MPN patients. Stay tuned for more enlightening perspectives!